Table 2 Clinical outcome of using the modified stent to treat BPF
Indicators | No of patients | % |
|---|---|---|
Initial success | 16 (16/17) | 94.1 |
 Successful stent placement | 17 (17/17) | 100 |
 Immediate cessation of air leakage | 16 (16/17) | 94.1 |
Clinical success | 13 (13/17) | 76.5 |
Decreased volume of drainage (empyema) | 11 (11/14) | 78.6 |
Disappearance of residual cavity | 6 (6/17) | 35.3 |
Shrinkage of the residual cavity | 10 (10/17) | 58.8 |
Remove of the stent | 7 (7/17) | 41.2 |
 For cured fistula | 4 (7/17) | 23.5 |
For granulomatous proliferation | 2 (2/17) | 11.8 |
 For stent migration | 1 (1/17) | 5.9 |
Main complications | 5 (5/17) | 29.4 |
 Exacerbation of pulmonary infection | 2 (2/17) | 11.8 |
 Severe granulomatous proliferation | 2 (2/17) | 11.8 |
 Stent migration | 1 (1/17) | 5.9 |